These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22496615)

  • 1. Dickkopf-1 expression is a novel prognostic marker for gastric cancer.
    Gao C; Xie R; Ren C; Yang X
    J Biomed Biotechnol; 2012; 2012():804592. PubMed ID: 22496615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
    Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
    World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezrin is associated with gastric cancer progression and prognosis.
    Li L; Wang YY; Zhao ZS; Ma J
    Pathol Oncol Res; 2011 Dec; 17(4):909-15. PubMed ID: 21717114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
    Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
    Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.
    Jiao X; Lu HJ; Zhai MM; Tan ZJ; Zhi HN; Liu XM; Liu CH; Zhang DP
    World J Gastroenterol; 2013 Dec; 19(48):9425-31. PubMed ID: 24409072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
    Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
    Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population.
    Lu X; Cheng C; Zhu S; Yang Y; Zheng L; Wang G; Shu X; Wu K; Liu K; Tong Q
    Oncol Rep; 2010 Oct; 24(4):981-7. PubMed ID: 20811679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C; Gao X; Liu H; Jiang T; Zhai X
    Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis.
    Ru GQ; Wang HJ; Xu WJ; Zhao ZS
    Pathol Oncol Res; 2011 Jun; 17(2):341-7. PubMed ID: 21104359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of IGFBP7 was a poor prognosis predictor for gastric cancer patients.
    Liu L; Yang Z; Zhang W; Yan B; Gu Q; Jiao J; Yue X
    Tumour Biol; 2014 Sep; 35(9):8875-81. PubMed ID: 24894674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
    Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
    J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer.
    Cheng WL; Wang CS; Huang YH; Liang Y; Lin PY; Hsueh C; Wu YC; Chen WJ; Yu CJ; Lin SR; Lin KH
    Int J Cancer; 2008 Oct; 123(8):1787-96. PubMed ID: 18688858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients.
    Zhao XF; Yang YS; Park YK
    Int J Clin Oncol; 2020 Dec; 25(12):2044-2054. PubMed ID: 32816159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.